Sign up for the QMED & MD+DI Daily newsletter.
Return of the Billion Dollar Medtech Deal
MD+DI Managing Editor Omar Ford speaks out on the recent rash of billion-dollar deals medtech has seen during the COVID-19 era.
It seems as if today’s climate would call for smaller tuck-in deals. But the opposite is happening in the medical devices and diagnostics. The industry has seen larger more robust deals that are stretching past the billion-dollar mark.
Teladoc Health’s $16.5 billion bid to acquire Livongo holds the record of being one of the largest deals to be announced during the pandemic era (so far). The acquisition is fueled by the rise in demand for virtual health.
But more million-dollar deals beyond the virtual health space are happening – such as the proposed Siemens Healthineers/Varian merger.
MD+DI Managing Editor Omar Ford delves deeper to get to the bottom of this growing trend.
About the Author(s)
You May Also Like
Pedersen's POV graphic featuring the headshot of MD+DI Senior Editor Amanda Pedersen and a pull quote from the latest edition of her opinion column.
BioSig's Ridiculously Sparse Layoff Announcement Reeks of CallousnessFeb 26, 2024|3 Min Read
Your Smartwatch Can’t Measure Blood Glucose Levels… YetFeb 26, 2024|3 Min Read
Medtech in a Minute: Medtronic Pulls the Plug on Ventilators and MoreFeb 26, 2024|1 Min Read
The Good, The Bad, and The Ugly in Medtech DealsFeb 23, 2024|9 Slides